Effects of povidone‐iodine composite on the elimination of bacterial biofilm
Authors:
- Leonita Pinto JeronimoLJLeonita Pinto Jeronimo
- Mi‐Ra ChoiMCMi‐Ra Choi
- Sun Hee YeonSYSun Hee Yeon
- Soo Kyoung ParkSPSoo Kyoung Park
- Young Hoon YoonYYYoung Hoon Yoon
- Seung Hyeon ChoiSCSeung Hyeon Choi
- Hwa‐Jung KimHwa‐Jung Kim
- In‐Taek JangIJIn‐Taek Jang
- Jeong‐Kyu ParkJPJeong‐Kyu Park
- Ki‐Sang RhaKRKi‐Sang Rha
- Yong Min KimYKYong Min Kim
- 1 June 2020
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 10 (7) , 884-892
Abstract
Background: Povidone‐iodine (PVP‐I) is well known as an antiseptic and exhibits extensive activity against various pathogens. However, due to its uniquely unpleasant nature, it cannot be used locally to deactivate various sinonasal pathogens. Therefore, we developed a PVP‐I composite that blocks the unpleasant odor of PVP‐I for use as a local antiseptic in the sinonasal cavity and evaluated its effect on bacterial biofilm's formation and elimination in in vivo and in vitro models.Methods: MTT, lactate dehydrogenase, and live/dead staining assay were performed to examine the cellular toxicity of PVP‐I composites on the primary human nasal epithelial and RPMI 2650 cells. Crystal violet assay was performed to quantify bacterial biofilm after treating with various agents, including PVP‐I and antibiotics. Hematoxylin‐and‐eosin staining, live/dead staining assay, and scanning electron microscopy were conducted to evaluate the effect of PVP‐I on biofilm formation in a mice biofilm model.Results: It was observed that the PVP‐I composite did not have any significant toxic effect on the nasal epithelial cells. Furthermore, the PVP‐I composite effectively inhibited the formation of bacterial biomass within a dose‐dependent manner after 48 hours of incubation with Pseudomonas aeruginosa and Staphylococcus aureus. In mice, it effectively eliminated biofilm from the mucosa of the nasal cavity and maxillary sinus at the tested concentrations.Conclusion: The results of this study indicate that the PVP‐I composite is a promising compound that could be used locally to prevent the formation of biofilms and to eliminate them from the sinonasal cavity.Keywords
Funding Information
- Chungnam National University (2017‐1919‐01)
- National Research Foundation of Korea (2017M3A9G5083517).)
This publication has 33 references indexed in Scilit:
- Inflammatory immune response in rabbits with Staphylococcus aureus biofilm–associated sinusitisInternational Forum of Allergy & Rhinology, 2018
- In vitro Multi-Species Biofilms of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Host Interaction during In vivo Colonization of an Otitis Media Rat ModelFrontiers in Cellular and Infection Microbiology, 2017
- Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteriaFEMS Microbiology Reviews, 2017
- Host Response to Staphylococcus epidermidis Colonization and InfectionsFrontiers in Cellular and Infection Microbiology, 2017
- Bacterial Biofilm Formation after Nasal Packing in Nasal Mucosa–wounded MiceAmerican Journal of Rhinology & Allergy, 2013
- From in vitro to in vivo Models of Bacterial Biofilm-Related InfectionsPathogens, 2013
- Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis?The Laryngoscope, 2011
- Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa BiofilmsAntimicrobial Agents and Chemotherapy, 2004
- Biofilms: Microbial Life on SurfacesEmerging Infectious Diseases, 2002
- Bacterial Biofilms: A Common Cause of Persistent InfectionsScience, 1999